Interactive discussion and Q&A

Back

Open Access

Interactive discussion and Q&A

Session: The clinical continuum of atrial fibrillation: balancing risks to optimise outcomes

Topic: Oral Anticoagulant Drugs

Speaker: Professor G. Lip (Liverpool, GB) Doctor E. Svennberg (Stockholm, SE) Professor D. Connolly (Smethwick, GB)

About the speakers

Professor Gregory Yh Lip

University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)

114 presentations

16 followers

Doctor Emma Svennberg

Karolinska Institute, Stockholm (Sweden)

46 presentations

26 followers

Professor Derek Connolly

Midland Metropolitan University Hospital, Smethwick (United Kingdom of Great Britain & Northern Ireland)

29 presentations

1 follower

4 more presentations in this session

Welcome and introduction

Speaker: Professor G. Lip (Liverpool, GB)

Access

Slides

Balancing atrial fibrillation burden with stroke risk and the need for anticoagulation

Speaker: Doctor E. Svennberg (Stockholm, SE)

Access

Slides

Updates on the latest real-world evidence on the use of direct oral anticoagulants (DOAC) in non-valvular atrial fibrillation (NVAF)

Speaker: Professor G. Lip (Liverpool, GB)

Access

Slides

From data to decision-making: applying evidence and guidelines to clinical practice

Speaker: Professor D. Connolly (Smethwick, GB)

Access

Slides

Access the full session

The clinical continuum of atrial fibrillation: balancing risks to optimise outcomes

Speakers: Professor G. Lip, Doctor E. Svennberg, Professor D. Connolly, Professor G. Lip, Doctor E. Svennberg...

Access

Video

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources